Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.68 USD | -0.43% | -2.45% | +67.74% |
May. 01 | Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 | CI |
Apr. 12 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 6.510 | 6.510 | 5.810 |
Spread/Res. | -28.11% | -28.11% | -19.45% |
Spread/Supp. | +15.84% | +15.84% | +29.64% |
Support | 4.040 | 4.040 | 3.610 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LPCN Stock
- Charts Lipocine Inc.